Impact of glucose lowering on CKD progression
10:00 AM - 11:00 AM CST (Chicago/Mexico City Time),
5:00 PM - 6:00 PM (Paris/Brussels Time),
9:30 PM - 10:30 PM (New Delhi/Mumbai Time),
12:00 AM - 1:00 AM (Singapour/Beijing Time).
Historically, glycemic control has not been associated with a significant slowing of CKD progression. More recently, very long term epidemiological studies spanning more than 25-30 years demonstrate a benefit of glycemic control on slowing nephropathy progression.
This webinar will focus on outcome data evaluating CKD progression in the context of glycemic control, as well as data from short versus long term studies that evaluates the impact of glycemic control on CKD progression.
Professor George Bakris
Dr. George Bakris is Professor at the University of Chicago Medicine where he directs the Comprehensive Hypertension Center and the Hypertension Fellowship Program as well as the Clinical Research Labs where ongoing clinical trials occur. He has more than 700 publications and book chapters and is the Editor of 18 books in the areas of hypertension and diabetic kidney disease.
A Webinarium a jelzett időpontban megtekinthető ide kattintva >>